Day: October 28, 2024

Please find attached announcementsAttachmentAndri – Sniðmát fyrir tilkynningu og opinbera birtingu viðskipta einstaklinga sem gegna stjórnun – Þjónustugátt – Seðlabanki Ísl

NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) — WeRide, the leading global commercial-stage company, was officially listed on the Nasdaq Global Select Market under the ticker symbol “WRD.” Upon listing, WeRide became the world’s first publicly listed universal autonomous driving technology company and the first publicly listed Robotaxi company. The initial public offering price was set at $15.5 per American depositary share (ADS). If the underwriters fully exercise the granted option, the Company will issue a total of 8,903,760 ADSs. The total proceeds from the public offering, combined with $320 million concurrent private placement, are expected to amount to $458.5 million, assuming the underwriters of the initial public offering fully exercise their option.Tony Han, Founder and CEO of WeRide, stated: “Seven years...

TORONTO, Oct. 28, 2024 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”) is pleased to announce that it has joined the United Nations Global Compact (UNGC), the world’s largest corporate sustainability initiative. This membership reflects Lithium Ionic’s commitment to advancing the United Nations Sustainable Development Goals (SDGs) and embracing the Ten Principles, which emphasize human rights, labour, environmental responsibility, and anti-corruption practices. As a member of this global network of over 25,000 companies, Lithium Ionic reinforces its dedication to addressing key global challenges, including climate action, gender equality, poverty reduction, and biodiversity protection. Participation in the UNGC requires annual reporting on progress, ensuring transparency...

PRINCETON, N.J., Oct. 28, 2024 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Wednesday, November 6, 2024, at 8:30 a.m. ET to discuss financial results for the third quarter ended September 30, 2024. Participants and investors interested in accessing the call by phone will need to register using the online registration form. After registering, all phone participants will receive a dial-in number along with a personal PIN to access the event. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call. An archived webcast and accompanying...

PITTSBURGH, Oct. 28, 2024 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its third quarter 2024 financial results on Monday, November 4, 2024, prior to the open of U.S. markets. The Company’s management will also host a conference call and webcast at 8:30 am ET on Monday, November 4, 2024, to discuss the financial results and provide a business update. Investors and the general public can access the live webcast at: https://www.webcaster4.com/Webcast/Page/3018/51458. For those unable to listen to the live webcast, a replay will be available for 30 days on the Investors section of the Company’s website at www.krystalbio.com. About Krystal Biotech, Inc.Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage biotechnology company...